Why it matters: In 2015 NHS England were required to recommend to GPs that when used for pain pregabalin should be prescribed as the branded product Lyrica, in order to be in line with the patent. In July 2017 this guidance was rescinded as the patent for pain had expired. Costs of the generic product fell sharply in August 2017, and practices should now follow normal practice for prescribing, i.e. usually prescribe by the generic name.
Description: Total quantity of Lyrica capsules, as a proportion of total capsules of pregabalin.
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.